391 - 393 |
Introduction: Antibiotic resistance Walsh C, Wright G |
395 - 424 |
Bacterial resistance to beta-lactam antibiotics: Compelling opportunism, compelling opportunity Fisher JF, Meroueh SO, Mobashery S |
425 - 448 |
Glycopeptide and lipoglycopeptide antibiotics Kahne D, Leimkuhler C, Wei L, Walsh C |
449 - 475 |
Chemistry and biology of ramoplanin: A lipoglycodepsipeptide with potent antibiotic activity Walker S, Chen L, Hu YN, Rew Y, Shin DW, Boger DL |
477 - 497 |
Molecular insights into aminoglycoside action and resistance Magnet S, Blanchard JS |
499 - 527 |
Translation and protein synthesis: Macrolides Katz L, Ashley GW |
529 - 542 |
Streptogramins, oxazolidinones, and other inhibitors of bacterial protein synthesis Mukhtar TA, Wright GD |
543 - 558 |
Genetic approaches to polyketide antibiotics. 1 McDaniel R, Welch M, Hutchinson CR |
559 - 592 |
Bacterial topolsomerase inhibitors: Quinolone and pyridone antibacterial agents Mitscher LA |
593 - 620 |
DNA and RNA synthesis: Antifolates Kompis IM, Islam K, Then RL |
621 - 632 |
Rifamycin-mode of action, resistance, and biosynthesis Floss HG, Yu TW |
633 - 683 |
Biosynthesis and mode of action of lantibiotics Chatterjee C, Paul M, Xie LL, van der Donk WA |
685 - 714 |
Thiopeptide antibiotics Bagley MC, Dale JW, Merritt EA, Xiong A |
715 - 738 |
Molecular mechanisms underlying nonribosomal peptide synthesis: Approaches to new antibiotics Sieber SA, Marahiel MA |
739 - 758 |
Antitumor antibiotics: Bleomycin, enedipes, and mitomycin Galm U, Hager MH, Van Lanen SG, Ju JH, Thorson JS, Shen B |
759 - 774 |
New targets and screening approaches in antimicrobial drug discovery Brown ED, Wright GD |